Claudia Henschke
Dr. Claudia Henschke is a professor of Radiology and the Director of the Early Lung Cancer Action Program (ELCAP) at the Icahn School of Medicine at Mount Sinai in New York City. She is a pioneer and leading expert in diagnostic radiology with more than 25 years of clinical and research experience with low-dose CT screening; and she has led the implementation of numerous city, state, national, and international lung screening programs. She is the founder of I-ELCAP. Since the 1992 start of the Early Lung Cancer Action Project (ELCAP) Dr. Henschke has worked on advancing research of early lung and cardiac diseases, with a particular focus on lung cancer screening. Dr. Henschke has authored over 500 peer-reviewed publications, two books, and many scientific presentations, and has trained more than 80 physician researchers. Prior to joining the faculty at Mount Sinai in 2010, she was a Professor of Radiology at Weill Cornell Medical College in New York City after starting her radiology career as an Associate Professor at the Brigham and Women’s Hospital at Harvard Medical School, in Boston Massachusetts.
Ella Kazerooni
Her professional focus as a cardiothoracic radiologist has been diffusing lung diseases and lung cancer. With the landmark ELCAP result, her focus shifted more towards early lung cancer detection and creating lung cancer survivors across the lung cancer continuum as the chair of the American Cancer Society National Lung Cancer Roundtable (ACS NLCRT). Her experiences in several organizations as board chair/president and through committee service have taught her a lot about working among the diversity of volunteers’ perspectives and expectations across the multipartite missions of clinical care, education, and research, including fundraising and membership engagement to focus on an organization’s mission. She catalyzed teams across a large organization at the American College of Radiology on lung cancer screening, from developing how radiologists interpret and report lung cancer screening exams (LungRADS) to building a screening registry to help practices understand and improve screening quality, including the commissions on economics, advocacy, education, and quality/ safety. Out of advocacy to Medicare for screening coverage, she found herself among a developing coalition of organizations and was foundational to the forming of the ACS NLCRT. She serves as the inaugural chair and has emphasized that their efforts must tackle the entire lung cancer continuum from prevention and early detection to guideline-concordant diagnostics and therapeutics, including biomarker testing, addressing stigma that clouds lung cancer patients in trying to receive health care and at a more societal level, and importantly to survivorship as we are creating more lung cancer survivors. It’s been a privilege and learning experience for her in this role, bringing together a coalition of nearly 200 organizations and making a difference at the intersection of where activities can fall through the cracks between the efforts of individual specialty-based organizations and the best efforts of health systems and individuals on the front lines of health care delivery.
Helmut Prosch
Helmut Prosch, MD, is an Associate Professor of Radiology and the section chief of thoracic imaging at the Department of Biomedical Imaging and Image-guided Therapy at the Medical University of Vienna, Austria. He obtained his medical degree in 2000 from the University of Vienna and trained in Radiology at the Otto Wagner Hospital in Vienna. Previously, he worked as a research fellow at the Children’s Cancer Research Institute in Vienna.
Dr. Prosch’s research primarily focuses on the diagnosis and staging of lung cancer, as well as the application of deep learning in predicting treatment response on lung cancer and in diagnosing diffuse parenchymal lung diseases. He has authored more than 250 articles, reviews, and book chapters, and serves as the deputy editor of European Radiology. Additionally, he is the current president elect of the European Society of Thoracic Imaging (ESTI).
Dr. Prosch is part of the coordination team for the EU-funded project “Strengthening the Screening of Lung Cancer in Europe” (SOLACE), which seeks to advance the implementation of lung cancer screening programs across Europe. As part of this initiative, he leads Work Package 7, dedicated to sustainability and training.
Dr. Prosch served as a member of the organizing committee of the World Conference on Lung Cancer in 2016 and in 2022 as a co-chair. Since 2026 he has been a member of the Member of the Staging and Prognostic Factors Group for the 9th and 10th Edition of the IASLC Staging Project.
Dorith Shaham
Dr. Dorith Shaham is the Director of CT and Cardiothoracic Imaging at the Department of Medical Imaging, Hadassah Ein Kerem, immediate Past Chair of the Clinical Educational Committee at the Hebrew University-Hadassah School of Medicine (2017-2023) and Deputy Editor of Journal of Thoracic Imaging (since 2018).
Dr. Shaham earned her MD from the Hebrew University-Hadassah School of Medicine in 1990 and completed her residency in Diagnostic Radiology at Hadassah in 1995. In 1997, she completed a Clinical Fellowship in the Division of Thoracic Radiology at the New York Hospital, Cornell Medical Center.
Upon her return to Israel and Hadassah, in 1998, Dr. Shaham established the first Lung Cancer Screening Program in Israel at Hadassah, as part of the International Early Lung Cancer Screening Program (I-ELCAP). She studied the cost-effectiveness of low-dose CT-based lung cancer screening in Israel and participated in multiple I-ELCAP studies, investigating various aspects related to lung cancer screening.
Dr. Shaham was a member and the radiology consultant of the Steering Committee appointed by the Israeli Ministry of Health, to establish a National Pilot Program for the Implementation of Lung Cancer Screening in Israel, which was active in 2020-2024. Following the experience gained in this program, Lung Cancer Screening was included in the Israeli Basket of Health Services in February 2025.
Dr. Shaham has significant experience in Medical Education. In 2007, she established a Medical Humanities Program at the Hebrew University-Hadassah Medical School, which she directed for 10 years. In her role as the Chairperson of the Clinical Educational Committee at the Hebrew University-Hadassah School of Medicine (2017-2023), she oversaw the clinical education program in her Medical School, and established multiple new courses, including Palliative and End-of-Life care, Integrative Medicine and Inter-professional Education (IPE).